Zilascorb
Alternative Names: P 1015; ZoxxozLatest Information Update: 15 Dec 1998
At a glance
- Originator Pronova Biocare
- Class Antineoplastics
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer; Malignant melanoma; Ovarian cancer; Pancreatic cancer